Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS) has reported earnings 21 times since May 06, 2021. The stock moves an average of ±5.51% the day after reporting, closing higher 33.3% of the time. Its largest post-earnings gain was +11.54% (Mar 13, 2025) and its largest decline was -42.79% (May 18, 2026). The next earnings report is predicted for 2026-08-07 (approximate).
Earnings reactions
How GOSS moved on each past earnings report.
Earnings Impact
Total Earnings
21
Avg Abs. Movement
±5.51%
Positive %
33.3%
Negative %
66.7%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 18, 2026 | ☀ PRE | -42.79% | open_in_new |
| Mar 17, 2026 | ☽ POST | -8.05% | open_in_new |
| Nov 05, 2025 | ☽ POST | -2.53% | open_in_new |
| Aug 05, 2025 | ☽ POST | -8.33% | open_in_new |
Earnings Count
21
Total earnings in dataset
Avg Abs. Movement
±5.51%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260715 | open_in_new SEC.gov |
| 8-K | 20260701 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260701 | open_in_new SEC.gov |
| 8-K | 20260617 | open_in_new SEC.gov |
| SCHEDULE 13D | 20260611 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260611 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260611 | open_in_new SEC.gov |
| DEF 14A | 20260609 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260609 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
Frequently asked about GOSS earnings
When does Gossamer Bio, Inc. report earnings next? expand_more
Gossamer Bio, Inc. (GOSS)'s next earnings date is approximate for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does GOSS stock move after earnings? expand_more
Over 21 reports, GOSS has moved an average of ±5.51% the session after earnings, closing higher 33.3% of the time.
What was GOSS's biggest post-earnings move? expand_more
GOSS's largest post-earnings gain on record was +11.54% on Mar 13, 2025, and its largest decline was -42.79% on May 18, 2026.
Where can I find Gossamer Bio, Inc.'s SEC filings? expand_more
All of Gossamer Bio, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07